Health Velocity Capital

– IVX Health announced the completion of a $100m Series F minority investment from Great Hill Partners.
– Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.
– IVX Health offers an alternative to hospital-based infusion and injection services, transforming the patient experience by providing a superior level of service in a cost-effective, convenient site of care.
– IVX Health was also named to the prestigious Modern Healthcare Best Places to Work list for a third consecutive year. The organization continues to maintain an industry-leading 97 Net Promoter Score from its patient population.
– Evercore served as financial advisor to IVX Health and TripleTree, LLC served as financial advisor to Great Hill.

– Hospital IQ secured $25m in Series C funding led by Baxter Ventures, the venture investment arm of Baxter International Inc., and Health Velocity Capital, joining existing investors Pierpoint Capital and Allscripts.
– The investment comes amid a year of unprecedented company growth as its AI-enabled operations management platform solved operational inefficiencies, many of which were exacerbated by the pandemic, for hundreds of hospitals and health systems.
– Hospital IQ will use the funding to accelerate growth across all areas of the company, including product development, sales and marketing, and client services, and to spur further collaboration with its existing Allscripts and Cerner partnerships, as well as support new partnerships.